首页> Molecular therapy : the journal of the American Society of Gene Therapy> Systemic Injection of RPE65-Programmed Bone Marrow-Derived Cells Prevents Progression of Chronic Retinal Degeneration.

Systemic Injection of RPE65-Programmed Bone Marrow-Derived Cells Prevents Progression of Chronic Retinal Degeneration.

导出 OA

翻译打印收藏纠错

第一作者： Xiaoping,Qi

第一单位： Department of Ophthalmology, Eugene and Marilyn Glick Eye Institute, Indiana University School of Medicine, Indianapolis, IN 46202, USA.

作者： Xiaoping,Qi ^[1] ; S Louise,Pay ^[2] ; Yuanqing,Yan ^[3] ; James,Thomas ^[4] ; Alfred S,Lewin ^[4] ; Lung-Ji,Chang ^[4] ; Maria B,Grant ^[1] ; Michael E,Boulton ^[5]

作者单位： Department of Ophthalmology, Eugene and Marilyn Glick Eye Institute, Indiana University School of Medicine, Indianapolis, IN 46202, USA. ^[1] Department of Ophthalmology, Eugene and Marilyn Glick Eye Institute, Indiana University School of Medicine, Indianapolis, IN 46202, USA; Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN 46202, USA. ^[2] Department of Pharmacology and Therapeutics, University of Florida, Gainesville, FL 32610, USA. ^[3] Department of Molecular Genetics and Microbiology, University of Florida, Gainesville, FL 32610, USA. ^[4] Department of Ophthalmology, Eugene and Marilyn Glick Eye Institute, Indiana University School of Medicine, Indianapolis, IN 46202, USA. Electronic address: mboulton@iupui.edu. ^[5]

关键词 RPE65 adoptive transfer age-related macular degeneration bone marrow-derived cells cellular reprogramming retinal degeneration retinal pigment epithelium